Post-Transplant Recurrence of Neuroendocrine Tumors


Introduction: Recurrence after liver transplantation (LT) for metastases from NET is observed in 30-50% of cases at 5 years after LT but management is individualized

Aim(s): Aim of this study is to identify factors influencing post-recurrence survival and to define the best treatment according to disease presentation

Materials and methods: Consecutive patients treated at a single Institution for post-LT recurrence of NET were included. Baseline patients’ characteristics, primary tumor data, pre-transplant therapies, post-transplant recurrence and long term outcomes were collected and analyzed

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Monteleone M, Sposito C, Rossi R, Pusceddu S, Coppa J,

Keywords: Liver transplantation, Recurrence, Liver metastases,

To read the full abstract, please log into your ENETS Member account.